Sha Hu

Wuhan, 430071, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Cms1 Ribosomal Small Subunit Homolog Promotes HCC Proliferation and Migration by Modulating the TNF/NF-κB Signaling Pathway.

Cms1 Ribosomal Small Subunit Homolog Promotes HCC Proliferation and Migration by Modulating the TNF/NF-κB Signaling Pathway.

Journal: Journal of hepatocellular carcinoma
Published: June 23, 2025

Trim7 aggravates ischemic stroke-associated ferroptosis by promoting ubiquitin-mediated degradation of HSPA5.

Trim7 aggravates ischemic stroke-associated ferroptosis by promoting ubiquitin-mediated degradation of HSPA5.

Journal: Cell & bioscience
Published: June 05, 2025

USP43 promotes cerebral ischemia-reperfusion injury via activation of TAK1.

USP43 promotes cerebral ischemia-reperfusion injury via activation of TAK1.

Journal: Cell & bioscience
Published: May 29, 2025

Fas apoptotic inhibitor molecule 2 mitigates metabolic dysfunction-associated fatty liver disease through autophagic CRTC2 degradation.

Fas apoptotic inhibitor molecule 2 mitigates metabolic dysfunction-associated fatty liver disease through autophagic CRTC2 degradation.

Journal: Experimental & molecular medicine
Published: February 26, 2025

E3 Ubiquitin Ligase TRIM7 Alleviates Lipopolysaccharide-Induced Acute Lung Injury via Inhibiting NLRP3 Inflammasome Activation.

E3 Ubiquitin Ligase TRIM7 Alleviates Lipopolysaccharide-Induced Acute Lung Injury via Inhibiting NLRP3 Inflammasome Activation.

Journal: The American journal of pathology
Published: August 29, 2024

USP29 alleviates the progression of MASLD by stabilizing ACSL5 through K48 deubiquitination.

USP29 alleviates the progression of MASLD by stabilizing ACSL5 through K48 deubiquitination.

Journal: Clinical and molecular hepatology
Published: June 25, 2024

Tripartite motif 38 alleviates the pathological process of NAFLD-NASH by promoting TAB2 degradation.

Tripartite motif 38 alleviates the pathological process of NAFLD-NASH by promoting TAB2 degradation.

Journal: Journal of lipid research
Published: March 01, 2023

Lysosomal-associated protein transmembrane 5 ameliorates non-alcoholic steatohepatitis by promoting the degradation of CDC42 in mice.

Lysosomal-associated protein transmembrane 5 ameliorates non-alcoholic steatohepatitis by promoting the degradation of CDC42 in mice.

Journal: Nature communications
Published: September 14, 2022

Breviscapine alleviates NASH by inhibiting TGF-β-activated kinase 1-dependent signaling.

Breviscapine alleviates NASH by inhibiting TGF-β-activated kinase 1-dependent signaling.

Journal: Hepatology (Baltimore, Md.)
Published: June 14, 2021

Gastrodin Improves Nonalcoholic Fatty Liver Disease Through Activation of the Adenosine Monophosphate-Activated Protein Kinase Signaling Pathway.

Gastrodin Improves Nonalcoholic Fatty Liver Disease Through Activation of the Adenosine Monophosphate-Activated Protein Kinase Signaling Pathway.

Journal: Hepatology (Baltimore, Md.)
Published: June 03, 2021

The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin-Mediated Degradation of 3-Hydroxy-3-Methylglutaryl CoA Reductase Degradation Protein 1.

The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin-Mediated Degradation of 3-Hydroxy-3-Methylglutaryl CoA Reductase Degradation Protein 1.

Journal: Hepatology (Baltimore, Md.)
Published: May 24, 2021

SIMPLE Is an Endosomal Regulator That Protects Against NAFLD by Targeting the Lysosomal Degradation of EGFR.

SIMPLE Is an Endosomal Regulator That Protects Against NAFLD by Targeting the Lysosomal Degradation of EGFR.

Journal: Hepatology (Baltimore, Md.)
Published: May 12, 2021
Showing 1-12 of 15

Last Updated: 09/26/2026